Systematic review of the prevalence of mycobacterium tuberculosis resistance in Saudi Arabia

Journal of Chemotherapy

Volumn 27, Issue 6, 2015, Pages 378-382

  Al Tawfiq, Jaffar A ^a,b   Hinedi, Kareem ^a   Memish, Ziad A ^c  

^a DHAHRAN HEALTH CENTER   (Saudi Arabia)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ALFAISAL UNIVERSITY   (Saudi Arabia)

Author keywords

Resistance; Saudi Arabia; Systematic review; Tuberculosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

DATA EXTRACTION; HUMAN; META ANALYSIS; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; REVIEW; SAUDI ARABIA; SYSTEMATIC REVIEW (TOPIC); DRUG EFFECTS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

ANTITUBERCULAR AGENTS; HUMANS; ISONIAZID; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; RIFAMPIN; SAUDI ARABIA; STREPTOMYCIN; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84954067904     PISSN: 1120009X     EISSN: 19739478     Source Type: Journal    
DOI: 10.1179/1973947815Y.0000000058     Document Type: Review

References (37)

1. World Health Organization. Global tuberculosis control 2009: a short update to the 2009 report. Geneva, Switzerland: (WHO/HTM/TB/2009 426); 2010.
2. Ministry of Health. Health statistical year book 1428 H (2007). Riyadh, Saudi Arabia 2008.
3. Abouzeid MS, Zumla AI, Felemban S, Alotaibi B, O'Grady J, Memish ZA. Tuberculosis trends in Saudis and non-Saudis in the Kingdom of Saudi Arabia - a 10 year retrospective study (2000-2009). PLoS One. 2012;7(6):e39478.
4. Khan MY, Kinsara AJ, Osoba AO, Wali S, Samman Y, Memish Z. Increasing resistance of M. tuberculosis to anti-TB drugs in Saudi Arabia. Int J Antimicrob Agents. 2001;17:415-8.
5. Abu-Amero KK. Status of antituberculosis drug resistance in Saudi Arabia 1979-98. East Mediterr Health J. 2002;8:664-70.
6. Alrajhi AA, Al-Barrak AM. Mycobacterium tuberculosis susceptibility in Saudi Arabia. Saudi Med J. 2002;23:1227-31.
7. Al-Hajoj SA. Tuberculosis in Saudi Arabia: can we change the way we deal with the disease? J Infect Public Health. 2010;3:17-24.
8. Yezli S, Memish ZA. Tuberculosis in Saudi Arabia: prevalence and antimicrobial resistance. J Chemother. 2012;24(1):1-5.
9. Neyeloff JL, Fuchs SC, Moreira LB. Meta-analyses and forest plots using a microsoft excel spreadsheet: step-by-step guide focusing on descriptive data analysis. BMC Res Notes. 2012;5:52.
10. Whitehead A, Whitehead J. A general parametric approach to the metaanalysis of randomized clinical trials. Stat Med. 1991;10:1665-77.
11. 16.9.2 Studies with Zero-Cell Counts. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0. [updated March 2011]. In: Julian PT Higgins J and S Green, Editors. Available from: http://handbook.cochrane.org/front_page.htm
12. Williams JG, Higgins JP, Brayne CE. Systematic review of prevalence studies of autism spectrum disorders. Arch Dis Child. 2006;91(1):8-15.
13. How to draw a funnel plot in Microsoft Excel. Available from: http://www.kurtosis.co.uk/technique/funnel/
14. Kordy FN, Al-Thawadi S, Alrajhi AA. Drug resistance patterns of Mycobacterium tuberculosis in Riyadh, Saudi Arabia. Int J Tuberc Lung Dis. 2004;8:1007-11.
15. al-Orainey IO, Saeed ES, el-Kassimi FA, al-Shareef N. Resistance to antituberculosis drugs in Riyadh, Saudi Arabia. Tubercle. 1989;70:207-10.
16. Al-Hajjaj MS, Al-Kassimi FA, Al-Mobeireek AF, Alzeer AH. Progressive rise of Mycobacterium tuberculosis resistance to rifampicin and streptomycin in Riyadh, Saudi Arabia. Respirology. 2001;6(4):317-22.
17. Ellis ME, al-Hajjar S, Bokhari H, Hussein Qadri SM. High proportion of multi-drug resistant Mycobacterium tuberculosis in Saudi Arabia. Scand J Infect Dis. 1996;28:591-5.
18. al-Orainey IO. Resistance to standard antituberculous drugs in Saudi Arabia. Saudi Med J. 1986;7:363-8.
19. Shanks NJ, Khalifa I, Al-Kalai D. Tuberculosis in Saudi Arabia. Saudi Med J. 1983;4:151-6.
20. Chowdhury MNH, Kambal AM. Mycobacterial resistance in a general hospital in Riyadh Saudi Arabia. Med Sci Res. 1992;20:21-2.
21. Singla R, Al-Sharif N, Al-Sayegh M, Osman M, Shaikh MA. Prevalence of resistance to antituberculosis drugs in Riyadh and a review of previous reports. Ann Saudi Med. 2003;23(3-4):143-7.
22. Al-Rasheed AM, Abu-Amero KK, Abdulsamad W, Alattayah S. Low prevalence of multi-drug resistance tuberculosis in Saudi patients: an eleven-year retrospective study (abstract). In: 20th Annual Congress of the European Society of Mycobacteriology; 1999; Lucerne, Switzerland.
23. Somily AM, Naeem T, Habib HA, Sarwar MS, Kunimoto DY, Kambal AM. Changing epidemiology of tuberculosis detected by an 8-year retrospective laboratory study in a tertiary teaching hospital in central Saudi Arabia. Saudi Med J. 2014;35(7):691-8.
24. Kinsara A, Gilpin C, Osoba A. Review of tuberculosis at the King Khalid National Guard Hospital, Jeddah, Saudi Arabia. Saudi Med J. 1997;19:212-4.
25. Zaman R. Tuberculosis in Saudi Arabia: initial and secondary drug resistance among indigenous and nonindigenous populations. Tubercle. 1991;72:51-5.
26. Al-Jama AA, Borgio FG, Al-Qatari KM. Patterns of resistance to antituberculous drugs in Eastern Province, Saudi Arabia. Saudi Med J. 1999;20:927-30.
27. Al-Tawfiq JA, Al-Muraikhy AA, Abed MS. Susceptibility pattern and epidemiology of Mycobacterium tuberculosis in a Saudi Arabian hospital. Chest. 2005;128:3229-32.
28. Al-Rubaish AM, Madania AA, Al-Muhanna FA. Drug resistance pulmonary tuberculosis in the Eastern Province of Saudi Arabia. Saudi Med J. 2001;22:776-9.
29. Ali Chaudhry L, Rambhala N, Al-Shammri AS, Al-Tawfiq JA. Patterns of antituberculous drug resistance in Eastern Saudi Arabia: a 7-year surveillance study from 1/2003 to 6/2010. J Epidemiol Glob Health. 2012;2(1):57-60.
30. Al-Hajoj S, Varghese B, Shoukri MM, Al-Omari R, Al-HerbwaiM,AlrabiahF, et al.Epidemiology of antituberculosis drug resistance in Saudi Arabia: findings of the first national survey. Antimicrob Agents Chemother. 2013;57(5):2161-6.
31. Alrajhi AA, Abdulwahab S, Almodovar E, Al-Abdely HM. Risk factors for drug-resistant Mycobacterium tuberculosis in Saudi Arabia. Saudi Med J. 2002;23:305-10.
32. Schiott C, Engbaek H, Vergmann B, Al-Motez M, Kassim I. Incidence of drug resistance amongst isolates of Mycobacterium tuberculosis recovered in Gizan area, Saudi Arabia. Saudi Med J. 1985;6:375-8.
33. Asaad AM, Alqahtani JM. Primary anti-tuberculous drugs resistance of pulmonary tuberculosis in southwestern Saudi Arabia. J Infect Public Health. 2012;5(4):281-5.
34. Jarallah JS, Elias AK, Al Hajjaj MS, Bukhari MS, Al-Shareef AH, Al-Shammari SA. High rate of rifampicin resistance of Mycobacterium tuberculosis in the Taif region of Saudi Arabia. Tuber Lung Dis. 1992;73:113-5.
35. Al-Rajhi AA, Al-Barrak AM. Extra-pulmonary tuberculosis, epidemiology and patterns in Saudi Arabia. Saudi Med J. 2002;23:503-8.
36. Al-OtaibiF,ElHazmiMM.Extra-pulmonary tuberculosis in Saudi Arabia. Indian J PatholMicrobiol. 2010;53(2):227-31.
37. The WHO Global TB Report. 2013. Available from: https://extranet. who.int/sree/Reports?op5Replet&name5%2FWHO_HQ_ Reports%2FG2%2FPROD%2FEXT%2FTBCountryProfile& I SO25SA&LAN5EN&outtype5pdf